Galena Biopharma In The News
- Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer
- Galena Biopharma Reports Second Quarter 2014 Results
- Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014
- Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film
Galena is committed to ensuring eligible patients have access to our products. Learn more at GalenaPatientServices.com.